Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutically Applicable Research to Generate Effective Treatments (TARGET) for Neuroblastoma

NCT01169376 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01169376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01169376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutically Applicable Research to Generate Effective Treatments (TARGET) for Neuroblastoma
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
July 31, 2010
Completion date
May 31, 2016
Enrollment
380 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma